|
Medication Sheets |
||
|
|
||
|
Stay the course, Full speed ahead.. |
||
|
Drug Name |
(Adenocard) |
|
Mechanism Of Action |
· Slows Conduction through AV node · Interrupts AV nodal reentry pathways |
|
Indications |
· Defined, stable, narrow-complex AV or sinus nodal reentry tachycardia (reentry SVT) · ACLS Class I Recommendation |
|
Precautions |
· Transient bradycardia (asystole!), ventricular ectopy, flushing, dyspnea, and chest pain · Caution in patients prone to bradycardia or conduction defects without pacemaker |
|
Misc (drug interactions) |
· Reduce dose to 3 mg – Dispyridamole, Carbamazepine, Cardiac Transplant, CVL Admin · Dose at 12 mg – Theophylline, Caffeine |
|
Diagnostic |
· Undefined, stable narrow-complex SVT · Will not convert atrial tachycardias or VT as reentry not involving the AV or sinus node |
|
Dose |
· 6mg rapid IVP followed by immediate saline flush · May repeat with 12 mg rapid IVP followed by immediate saline flush if no conversion |
|
|
|
|
|
|
|
|
|
|
Drug Name |
(Proventil, Ventolin) |
|
Mechanism Of Action |
· Sympathomimetic, Beta2 selective adrenergic bronchodilator · |
|
Indications |
· Albuterol is used to treat reversible airway obstruction caused by · Wheezing associated with Asthma · COPD · Chronic Bronchitis |
|
Precautions |
· Hypersensitivity |
|
Misc (drug interactions) |
· Beta adrenergic agents – potentiates the effects · MAO inhibitors-may lead to hypertensive crisis · Beta adrenergic blockers-decreases effectiveness |
|
Dose |
· Adult - (2.5-5 mg) up to (10mg) in 3 ml sterile NS, inhaled of 5-10 minutes · Pedi - (2.5-5 mg) up to (5mg) in 3 ml sterile NS, inhaled of 5-10 minutes |
|
Special Notes |
· Most side effects are dosage related · May decrease arterial oxygen tension acutely by causing bronchodilation in areas of lungs with poor blood perfusion · Possible severe paradoxical airway resistance with repeated excessive use |
|
|
|
|
|
|
|
|
|
|
Drug Name |
(Cordarone) |
|
Mechanism Of Action |
· Delays repolarization (prolongs refractory period) · Blocks A & B adrenergic receptors · Affects sodium, potassium, and calcium channels |
|
Indications |
· Persistent pr recurrent VF / pulseless VT · ACLS Class II Recommendation · Effective in Atrial & Ventricular arrythmias |
|
Precautions |
· Hypotension, dizziness, fatigue, N/V · Significant bradycardia & heart block · Pulmonary & hepatic toxicities |
|
Misc (drug interactions) |
· Provided as 150 mg syringe · Multiple drug interactions |
|
Dose |
· Cardiac Arrest(VF/pulseless VT) given as 300 mg rapid IV infusion in 20-30 mL D5W · One supplement dose of 150 mg may be given in 3-5 min if refractory VF/pulsless VT · VT(with pulse), dose is 150 mg IV every 10 minutes |
|
Continuous Infusion Dose |
· Max of 2.2 grams/24 hours · 150 mg in 50 mL D5W over 10 minutes |
|
|
Please read and study local Protocols |
|
|
|
|
|
|
|
Drug Name |
|
|
Mechanism Of Action |
· Enhances sinus node automaticity & AV conduction · Parasympatholytic (direct vagolytic action) |
|
Indications |
· Symptomatic bradycardia
|
|
Precautions |
· Existing tachycardia · Avoid in hypothermic bradycardia · Increases myocardial O2 demand |
|
Misc |
· May be used for organophosphate poisoning · Extremely large doses may be needed in this case (2-4 mg or higher with exposure to nerve agent) |
|
Dose |
· Symptomatic Bradycardia: .5 mg IV · Doses less than .5 mg may cause paradoxical bradycardia · Do not delay pacing for symptomatic patients · Cardiac Arrest |
|
|
· Cardiac Arrest: 1 mg IV · Repeat dose every 5 minutes to total of 3 mg · Fully vagolytic at 3 mg · ACLS guideline for max dose is .04mg/kg · May give ET |
|
|
|
|
|
|
|
|
|
|
Drug Name |
(Diphenhydramine) |
|
Mechanism Of Action |
· Antihistamine · Blocks histamine receptors, has some sedative effect |
|
Indications |
· Anaphylaxis, allergic reactions, dystonic reactions due to phenothiazines |
|
Precautions |
· Hypotension · Asthma · Nursing Mothers |
|
Side Effect |
· Sedation, Dries bronchial secretions, blurred vision, headache, palpitations |
|
Diagnostic |
· Hives, Itching |
|
Dose |
· 25-50 mg Slow IV push or Deep IM · Pedi – 2-5 mg/kg |
|
|
|
|
|
|
|
|
|
|
Drug Name |
|
|
Mechanism Of Action |
· Carbohydrate · Elevates blood glucose level rapidly |
|
Indications |
· Hypoglycemia |
|
Precautions |
· A blood sample should be drawn before administration |
|
Misc Side Effects |
· Local venous irritation |
|
Diagnostic |
· Blood sugar less than 60mg/dl combined with a diminished level of consciousness |
|
Dose |
· 25 grams · Pedi - .5g/kg slow IV push; dilute 1:1 with sterile water to form a 25% solution |
|
|
|
|
|
|
|
|
|
|
Drug Name |
(Adrenaline) |
|
Mechanism Of Action |
· A and B adrenergic activity |
|
Indications |
· VF/ pulseless VT unresponsive to defib
|
|
Precautions |
· Tachycardia, hypertension, pulmonary edema · Myocardial Ischemia, Angina · Increased myocardial O2 demand · Overdose treatment is supportive |
|
Misc |
· Provided as 1:10,000 prefilled 10mL=1mg · Provided as 1:1000 vial 1 mL=1mg |
|
Dose |
· Standard dose = 1 mg every 3-5 minutes
· Follow dose with saline
· May be given ET
· Epinephrine Drip – Initiate at 1mcg/min, titrate to hemodynamic endpoint (2-10 mcg/min) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Drug Name |
(Intropin) |
|
Mechanism Of Action |
· Increases cardiac contractility, causes periphel vasoconstriction |
|
Indications |
· Hemodynamically significant hypotension, not resulting from hypovolemia, cardiogenic shock |
|
Precautions |
· Should not be administered in the presence of severe tachyarythmias · Should not be administered in the presence of ventricular fibrillation, ventricular irritability |
|
Misc (Contraindications) |
· Hypovolemic shock where complete fluid resuscitation has not occurred |
|
Dose |
· 400 mg in 250 cc of D5W IV add mixture at 10-30 microdrips/minute, titrate to BP |
|
|
|
|
|
|
|
|
|
|
|
|
|
Drug Name |
|
|
Indications |
· Hyperkalemia · ACLS class I recommendation · Tricyclic Antidepressant Overdose · ACLS class IIa recommendation · Phenobarbital overdose, preexisting acidosis, prolonged arres |
|
Dose |
· 1 mEq/kg initial, then ½ dose every 10 min |
|
Precautions |
· Monitor ABG’s, paradoxical acidosis due to CO2 diffusion & deleterious shift in oxygen dissociation curve
· ACLS class II recommendation if not intubated & hypercarbic acidosis |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Drug Name |
|
|
Mechanism Of Action |
· |
|
Indications |
· Torsades de pointes · ACLS class IIb recommendation if known or suspected hypomagnesaemia |
|
Dose |
· Dose based on patient stability: 1-2 gm · In 10 mL NS over 1-2 minutes in cardiac arrest · In 50 mL over 5-60 minutes in Torsades w/ pulse · Follow with infusion of .5 to 1 gm/hr for up to 24 hr |
|
|
|
|
Dose |
· |
|
|
|
|
|
|
|
|
|
|
|
|
|
Drug Name |
|
|
Mechanism Of Action |
· Naturally occurring antidiuretic hormone · Acts as non-adrenergic peripheral vasoconstrictor · Direct Stimulation of smooth muscle V1 receptors · No beta effects · Levels higher in patients who survive CPR |
|
Indications |
· VF/pulseless VT unresponsive to defib
|
|
Precautions |
· Hypertension, Tremor · Myocardial Ischemia, Angina · Overdose treatment is supportive · Consider osmotic diuretics if severe overdose |
|
Misc |
· Provided as 20 unit/mL ampule |
|
Dose |
· Dose is 40 units IV x 1 dose · Re-dosing (Class Indeterminate) · No response in 10-20 minutes, resume epi · Re-dosing vasopressin seems rational, but is not supported |
|
|
|
|
|
|
|
|
|
|
|
|
|
Drug Name |
(Narcan) |
|
Mechanism Of Action |
· Reverses opiate activities, including respiratory depression from natural & synthetic opioids |
|
Indications |
· Opiate or other Narcotic overdose |
|
Misc |
· Duration of 20-60 min, typically shorter than most opioids so will need repeat doses |
|
Dose |
· .4-2 mg every 2-3 minutes up to 10mg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Drug Name |
|
|
Mechanism Of Action |
· CNS depressant, causes peripheral vasodilatation, decreases sensitivity to pain |
|
Indications |
· Severe Pain, pulmonary edema |
|
Precautions |
· Respiratory depression, hypotension, nausea |
|
Misc |
· Dizziness, altered LOC |
|
Dose |
· 2-5 mg followed by 2 mg every few minutes until pain relief
· IM 5-15 mg based on patient weight
· Pedi- .1-.2 mg/kg IV |
|
|
|
|
|
|
|
|
|
|
|
|
|
Drug Name |
(Micronefrin, VapoNefrin) |
|
Mechanism Of Action |
· Sympathomimetic · Bronchodilation, Increases Heart Rate, Increases cardiac contractile force |
|
Indications |
· Croup |
|
Precautions |
· Vital Signs should be monitored · Use only once prehospital |
|
Misc Side Effects |
· Palpitations, anxiety, headache |
|
Dose |
· Inhalation only · .5-.75 ml of a 2.25% solution in 2.0 mL of NS · >1 or > 10 kg - .5 ml in 3 mL NS over 15 minutes · <1 or < 10 kg - .25 ml in 3 mL NSover 15 minutes |
|
|
|
|
|
|
|
|
|
|
|
|
|
Drug Name |
(Lasix) |
|
Mechanism Of Action |
· Inhibits reabsorption of sodium chloride, promotes promt diuresis, vasodilation |
|
Indications |
· Congestive heart failure |
|
Precautions |
· Protect from sunlight |
|
Misc Contraindications |
· Pregnancy, dehydration |
|
Dose |
· 40-80 mg IVP · Pedi – 1 mg/kg |
|
|
|
|
|
|
|
|
|
|
|
|
|
Drug Name |